Clinical Trials Logo

Filter by:
NCT ID: NCT00476983 Withdrawn - Clinical trials for Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

Pharmacokinetic and long term efficacy of TDF SQV film coated tablet 1500/100mg once daily plus TDF/FTC300/200mg once daily.

NCT ID: NCT00477867 Withdrawn - Ovarian Cancer Clinical Trials

Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172

Start date: n/a
Phase: N/A
Study type: Interventional

RATIONALE: Gathering information about patients with ovarian cancer over time may help doctors learn more about a patient's use of medical services and the cost of these services. PURPOSE: This clinical trial is collecting information about the patient's health and use of medical resources over time in patients with stage III ovarian cancer receiving paclitaxel and cisplatin on clinical trial GOG-172.

NCT ID: NCT00483210 Withdrawn - Clinical trials for Tissue Lipid Metabolism

Tissue Lipids and Insulin Resistance

Start date: n/a
Phase: N/A
Study type: Interventional

Resistance to the hypoglycemic action of insulin develops within 7 days of bedrest in young, healthy volunteers. We propose that the same event occurs in elderly individuals confined to bed, that alterations in lipid metabolism are, at least in part, responsible for the insulin resistance associated with bedrest, and that the accumulation of intracellular triglyceride (TG) in liver and muscle will play a role in impairing insulin action. Further, we propose that the PPARα (Peroxisome Proliferator-Activated Receptor Alpha) agonist fenofibrate will increase tissue fatty acid disposal by activating mitochondrial oxidative capacity, thereby improving insulin sensitivity. We will investigate a series of specific hypotheses designed to examine the role of altered lipid metabolism in the development of insulin-resistance associated with bedrest. Further, since inactivity is likely a principal factor in the development of insulin resistance in the elderly, the response to the inactivity imposed by bedrest represents an acceleration of the normal development of insulin resistance in elderly individuals. Therefore, the results of this study will also be pertinent to the understanding of the mechanisms responsible for the natural development of insulin resistance in free-living elderly.

NCT ID: NCT00486980 Withdrawn - Influenza Clinical Trials

Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

Start date: n/a
Phase: Phase 3
Study type: Interventional

This is a multinational, randomized, double-blind study comparing the efficacy and safety of two single dose regimens of peramivir administered intramuscularly versus placebo in adults with uncomplicated acute influenza.

NCT ID: NCT00487799 Withdrawn - Clinical trials for Heart Failure, Congestive

A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure

Start date: n/a
Phase: Phase 1
Study type: Interventional

To determine the maximum tolerated dose (MTD) of ularitide in the treatment of subjects hospitalized with symptomatic acute decompensated heart failure (ADHF).

NCT ID: NCT00498056 Withdrawn - HIV Infections Clinical Trials

Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa

Start date: n/a
Phase: Phase 2
Study type: Interventional

The development of a safe and effective vaccine is the best strategy for preventing the spread of HIV-1. The purpose of this study is to determine the safety and effectiveness of and immune responses to an HIV vaccine regimen in healthy adults at risk for HIV infection.

NCT ID: NCT00502294 Withdrawn - Clinical trials for Intravenous Steroid-Refractory Ulcerative Colitis

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

To compare the efficacy of visilizumab at 5 mcg/kg/day administered intravenously (IV) on Days 1 and 2 to placebo in subjects with IVSR-UC.

NCT ID: NCT00505258 Withdrawn - Bacteremia Clinical Trials

Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of ceftobiprole versus a comparator in hospitalized patients with bacteremia.

NCT ID: NCT00506610 Withdrawn - Clinical trials for Postherpetic Neuralgia

A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether T-62 is effective in providing relief of pain that can occur after an individual experiences a shingles outbreak, which is an infection in adults caused by the same virus that causes chicken pox.

NCT ID: NCT00517972 Withdrawn - Depression Clinical Trials

Omacor for Perimenopausal Depression

Start date: n/a
Phase: Phase 2
Study type: Interventional

Recently, antidepressants and other similar acting agents have been explored as a class of medications to treat major depressive disorder (MDD) in the context of perimenopause, as well as the somatic symptoms of perimenopause (such as hot flashes). Omega-3 fatty acids, which include eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are nutritional compounds with widely established health benefits and which occur naturally in fish and marine sources. Results of previous mood disorder studies have indicated that omega-3 fatty acids may be of help in the treatment of depression. Therefore, the current study is designed to examine the effectiveness and tolerability of the study drug, Omacor, (omega-3 fatty acid ethyl esters), in the treatment of major depressive disorder in perimenopausal women.